Gram negative infections in burns and their chemotherapy.
D000328:Adult; D002056:Burns / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D002058:Burns, Electric / Q000150:complications / Q000382:microbiology; D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003091:Colistin / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010357:Patient Isolators; D010406:Penicillins / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000473:pathology; D018805:Sepsis / Q000188:drug therapy; D012835:Silver Nitrate / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use; D014050:Toluene
D005839:Gentamicins; D010406:Penicillins; D011113:Polymyxins; D013449:Sulfonamides; D014050:Toluene; D012835:Silver Nitrate; D003091:Colistin